P Olin
- Microbiology top 0.1%
- Bacterial Infections and Vaccines 38
- Epidemiology top 1%
- Pneumonia and Respiratory Infections 24
- Influenza Virus Research Studies 7
- Virology and Viral Diseases 4
- Endocrinology top 2%
- Health top 5%
- Vaccine Coverage and Hesitancy 15
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 6
-
- Peripheral Neuropathies and Disorders 7
-
- Thyroid Disorders and Treatments 4
- Co-authors
- Hans O. HallanderJann StorsæterLennart GustafssonElisabet ReizensteinS. ROSENFinn RasmussenLea Nørgreen GustafssonHarald Heijbel
- Partner nations
- SwedenUnited StatesItaly
In The Last Decade
P Olin
67 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Microbiology 1.9k
- Epidemiology 1.9k
- Endocrinology 175
- Health 229
- Infectious Diseases 496
Countries citing papers authored by P Olin
This map shows the geographic impact of P Olin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Olin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Olin more than expected).
Fields of papers citing papers by P Olin
This network shows the impact of papers produced by P Olin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Olin. The network helps show where P Olin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P Olin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [Polio close to eradication]. | 2017 | 6 |
| 2 | 2014 | 9 | |
| 3 | 2010 | 16 | |
| 4 | 2010 | 1 | |
| 5 | 2004 | 16 | |
| 6 | 2003 | 94 | |
| 7 | 2003 | 99 | |
| 8 | 2001 | 45 | |
| 9 | 2000 | 53 | |
| 10 | 2000 | 46 | |
| 11 | 2000 | 97 | |
| 12 | 1999 | 46 | |
| 13 | 1998 | 389 | |
| 14 | 1997 | 246 | |
| 15 | A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis Vaccinebreakdown → | 1996 | 576 |
| 16 | 1993 | 48 | |
| 17 | 1990 | 98 | |
| 18 | Invasive Bacterial Infections during an Efficacy Trial of Acellular Pertussis Vaccines-Implications for Future Surveillance in Pertussis Vaccine Programmes(B. Vaccine Schedules: Their Pelationship to Current Epidemiology)(II. The Eradication of Pertussis: Current Unsolved Epidemiologic, Clinical and Public Health Problems which Impede This Goal)(Clinical Aspects of Acellular Pertussis Vaccines) | 1988 | 1 |
| 19 | 1988 | 39 | |
| 20 | 1971 | 1 |
About P Olin
P Olin is a scholar working on Microbiology, Health, Epidemiology, Infectious Diseases and Endocrinology, having authored 69 papers that have together received 2.8k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (38 papers), Pneumonia and Respiratory Infections (24 papers), Vaccine Coverage and Hesitancy (15 papers), Influenza Virus Research Studies (7 papers), Peripheral Neuropathies and Disorders (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Virology and Viral Diseases (4 papers) and Thyroid Disorders and Treatments (4 papers). The work is most often cited by research in Microbiology (1.9k citations), Epidemiology (1.9k citations), Endocrinology (175 citations), Health (229 citations) and Infectious Diseases (496 citations). P Olin has collaborated with scholars based in Sweden, United States and Italy. Frequent co-authors include Hans O. Hallander, Jann Storsæter, Lennart Gustafsson, Elisabet Reizenstein, S. ROSEN, Finn Rasmussen, Lea Nørgreen Gustafsson, Harald Heijbel, Luc Hessel and Elizabeth Miller. Their work appears in journals such as Acta Paediatrica, Vaccine, PEDIATRICS, JAMA and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.